Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nymox Pharmaceutical Corporation - Common Stock
(NQ:
NYMX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nymox Pharmaceutical Corporation - Common Stock
Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
July 25, 2023
NYMOZARFEX 15 mg Minimal Treatment of Low Grade Prostate Cancer Leads to Significant Long-Term Reduction in Incidence of Associated Prostate Cancer Surgery and Radiotherapy
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports on U.S. Patent Issuances
July 18, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Update
July 13, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox
July 12, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX Update
July 07, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Delisting from NASDAQ
July 05, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Provides Current Update
May 10, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Provides Corporate Update
April 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer
March 21, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Officially Granted Extension to Regain Listing Requirements
March 15, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review
February 15, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX Appeals Deficiency Letter
January 06, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPH
December 05, 2022
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
May 2023 Market Cap Requirement Update
November 25, 2022
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.